Notice of Intent to Sole Source for TaqMan Array Cards (2)
Closed Special Notice Posted
- Solicitation number
- 75D301-24-Q-78264
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Grand Island, New York 14072, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has issued a Special Notice for the intent to award a sole source firm fixed price purchase order to Life Technologies Corporation for TaqMan Array Cards. The TaqMan Array Cards are the only product that can be used for the spotting of reagents on 384 well cards, which are required for multi-pathogen testing of post-mortem specimens from enrolled cases in the Child Health and Mortality Prevention Surveillance (CHAMPS) program.
The purpose of this Special Notice is to inform the public of the CDC's intent to award a sole source contract to Life Technologies Corporation for the TaqMan Array Cards. The due date for any quotations or responses to this notice is September 3, 2024 at 4:00 PM PST. While this is not a request for competitive quotations, the government will consider any submissions received within 15 days of the issuance of this notice. The CDC has the sole discretion to determine whether to conduct a competitive procurement based on the responses received. The NAICS code for this requirement is 325413 - In-Vitro Diagnostic Substance Manufacturing, and the PSC code is 6550-P - In Vitro Diagnostic Substances, Reagents, Test Kits And Sets.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Life Technologies Corporation for TaqMan Array Cards. The TaqMan Array Cards (TAC) are the only product that can be used for the spotting of reagents on 384 well cards which are used for multi-pathogen testing of post-mortem specimens from enrolled cases in the Child Health and Mortality Prevention Surveillance (CHAMPS) program. The TACs are microfluidic arrays containing 20-40 CDC-developed PCR assays in customized configurations. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP).
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at xse6@cdc.gov by September 3, 2024 at 4:00 PM PST.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement | CDC Office of Acquisition Services | No set-aside | |
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity